PepRank

Sermorelin

Also: GRF(1-29) · Geref (former US brand)

SleepRecoverySublingual / Injection

Short GHRH analogue; cheap, gentle, sleep-focused, still GH/IGF-1 axis.

Safety tier
Avoid
strict bar
Positive
46%
of 29 reports
Per month
≈ €38–94
injected
Rank
#42
of 61 research peptides

At a glance

Access
Prescription (compounded)
InjectionLasts 2 h

Builds over days or weeks of regular use rather than with each dose.

Strict case
GH/IGF-1 axis elevation, though the mildest of the class.
Best effects
Sleep quality · recovery · IGF-1 into upper-normal range
Downsides
Weaker than alternatives · flushing · injection-site reactions
Typical use
200-500 mcg nightly subQ, 5-7 nights/week.
Stacked with
Stacked with
TRT: The most common context; clinics sell it as an add-on to testosterone, and several users credit the testosterone rather than the sermorelin for their results. · Tirzepatide or retatrutide: Taken to hold on to muscle during GLP-1 weight loss; most visible fat-loss results in these threads come from the GLP-1. · Ipamorelin: A cheaper alternative to CJC-1295/ipamorelin; one user's improved sleep turned into 3 am waking and a pounding heartbeat once ipamorelin was added.

Safety

Watch
GH/IGF-1 axis elevation (glucose, theoretical neoplasm promotion) · Hypersensitivity reported across GH secretagogues
Tier by safety barStrict AvoidBalanced AvoidEvidence only Avoid
  • Seen harm2 of 3
  • Mechanism2 of 3
  • Data gap1 of 3
  • Silent harm3 of 3
  • Product1 of 3
Never if
Active cancer or a history of cancer · A previous reaction to CJC-1295, ipamorelin, tesamorelin or another GH secretagogue · Diabetes or impaired glucose tolerance · Pregnancy or breastfeeding (no human reproductive data)
Why each score
Seen harm 2/3
The Geref label lists only flushing and injection pain and FDA confirmed its 2008 withdrawal was commercial, but at least four independent first-hand reports describe anaphylaxis-type reactions (lip and face swelling, collapse with low blood pressure, an emergency visit), several in people sensitised by other GHRH or ghrelin-mimetic peptides: a consistent pattern. Geref 50 (sermorelin) SPC, HPRA Ireland ↗Federal Register 2013: Geref (sermorelin) not withdrawn for reasons of safety or effectiveness ↗r/BodyHackGuide: bad reaction to sermorelin (face and lip swelling, racing heart; collapse with low blood pressure in replies) ↗r/Peptidesource: sermorelin experience (emergency visit after injecting) ↗
Mechanism 2/3
A GHRH fragment that raises GH and IGF-1, though more weakly than the other secretagogues and with feedback preserved; the credible concerns are the IGF-1 axis's glucose and tumour-promotion effects. Prakash & Goa 1999: sermorelin review (BioDrugs, PubMed 18031173) ↗
Data gap 1/3
Approved in the US from 1990 to 2008 for diagnosis and paediatric GH deficiency, on small paediatric and diagnostic studies; no long-term adult data. Federal Register 2013: Geref (sermorelin) not withdrawn for reasons of safety or effectiveness ↗Prakash & Goa 1999: sermorelin review (BioDrugs, PubMed 18031173) ↗
Silent harm 3/3
Tumour promotion from raised IGF-1 would be silent and delayed, though IGF-1 and glucose can be tracked on blood tests.
Product 1/3
Mostly prescribed through US telehealth and compounding pharmacies; grey-market vials are the alternative. Mendias & Awan 2026 preprint: 6,441 grey-market peptide samples, 42-71% failed quality criteria, 15% had endotoxin ↗

User reports

All 29 reports →
Users report
A loyal minority rate it the budget GH option: they 'slept like a log', report better recovery, smoother skin and more energy, and see IGF-1 rise to the upper-normal range on bloodwork. Many call it weaker than CJC/Ipa or tesamorelin, and roughly a quarter notice nothing, often while starting TRT or a GLP-1 at the same time, which gets the credit. Vivid dreams, night sweats, water retention and acne recur. The most serious pattern is sensitisation: a dozen-plus first-hand accounts of hives, face and lip swelling, vomiting and collapse, sometimes needing the ER. These usually come on the second course or after earlier CJC/ipamorelin or tesamorelin use, but occasionally on the first dose.
Glowing 4Positive 9Mixed 4Nothing 4Negative 2Bad reaction 6
  • r/BodyHackGuide· · 48 upvotesOriginal ↗

    I started taking sermorelin about three weeks ago as a way to recover a little faster and sleep better because, let's face it, I'm not 22 anymore. Personally, I've noticed a massive difference in sleep, mood, energy levels, and performance in the gym.

    GlowingRecovery · Injection · 3 weeks

    35M, about 25% body fat

  • r/BodyHackGuide· · 7 upvotesOriginal ↗

    for the last couple of years (maybe 2) I’ve just felt like I’m dragging. I would sleep all of the time and it was never enough. The gym basically became nonexistent and I was a 5x/week gym goer. Ever since starting this, I just feel like my old (younger) self.

    GlowingEnergy · 10 days

    40s, new to peptides, testosterone low-normal

  • r/BodyHackGuide· · 6 upvotesOriginal ↗

    This was my first time trying Sermorelin. After injecting 500mcg, within minutes both of my hands started itching. Then I felt my lips and face swell up. My heart started to beat out of my chest and I started to sweat profusely.

    Bad reaction500 mcg · Injection · first dose

    prior cycles of tesamorelin and ipamorelin without problems

Where to buy

All 6 offers →
Getting it
Geref was withdrawn in 2008 for commercial reasons; US telehealth and TRT clinics now prescribe compounded injections, troches and nasal sprays. Also sold by research-peptide vendors.

A month at 200–500 mcg/day costs ≈ €38–94 from Prime Peptides at €6.29/mg, as no shop scoring 4 of 5 on trust lists it.

No trusted shop in the EU lists it; every listing is on the buy page.

Studies

Evidence
Approved drug — previously approved in US (Geref, pediatric GH deficiency; discontinued 2008)
2 more studies and 1 source

Sources

Molecule

Sequence
YADAIFTNSYRKVLGQLSARKLLQDIMSR
Length
29 amino acids
Modifications
GHRH(1-29), C-amide

Sequence

The peptide's chain of amino acids from its start (the N-terminus) to its end, one bead and one letter for each: A alanine, C cysteine, D aspartic acid, E glutamic acid, F phenylalanine, G glycine, H histidine, I isoleucine, K lysine, L leucine, M methionine, N asparagine, P proline, Q glutamine, R arginine, S serine, T threonine, V valine, W tryptophan, Y tyrosine. A modification such as an N-acetyl cap or a C-terminal amide changes how long it lasts in the body. Length tells related peptides apart, from a two-residue dipeptide like carnosine to a 43-residue protein like thymosin beta-4, and predicts neither effect nor safety.

Report grades

Every first-hand Reddit or X report is graded on its own, from glowing through positive, mixed, nothing and negative to bad reaction, and the bar shows how those grades split. Posts that look vendor-adjacent stay on the peptide's page but are left out of the counts.

GlowingPositiveMixedNothingNegativeBad reaction

% positive

The share of a peptide's graded Reddit and X reports that are glowing or positive, vendor-adjacent posts left out. A peptide with few reports is pulled toward the average of all reports, as if it had eight average ones besides its own, so two glowing posts cannot top the list. Peptides rank by this figure, those with no graded report yet after those with one, and Avoid ones after every other entry.

Researcher estimate

No first-hand report of this peptide has been graded yet, so the figure is the researchers' own rating out of 10 from what they read about it. It ranks after every peptide with graded reports until its own arrive.

Safety tier

Each peptide is tiered Clean, Caution or Avoid from its five risk axes under the chosen safety bar. An Avoid peptide carries a real risk of harm, a plausible route to serious harm rather than mere unpleasantness, so it stays listed with the reason but ranks behind every other entry, however good its reviews.

Safety bar

The safety bar sets how much risk it takes to rate a peptide Avoid. Strict: out on any serious mechanism with little human data, or any documented serious harm. Balanced: out on documented serious harm (unless it is obvious, reversible and from a regulated product), or a serious mechanism whose harm would be silent with no human data at all. Evidence only: out only on documented serious harm in humans that is lasting, delayed or from grey-market product.

Seen harm

Documented serious adverse events in humans, from 0 for none despite real exposure to 3 for deaths or several well-documented serious harms. Serious means a hospital or emergency visit or harm lasting weeks, so a headache or a bad night does not count.

Mechanism

A plausible biological route to serious harm at the doses people use, such as growth-factor signalling, hormone-axis suppression, heart or blood-pressure effects or immune activation. It runs from 0 when none is known to 3 when a dangerous pathway has been shown in living animals.

Data gap

How little human safety data exists for the molecule actually sold, from 0 for an approved drug with large trials and years of use to 3 for no human safety data at all. A modified analogue does not inherit its parent's trials.

Silent harm

Whether the feared harm would show quickly or stay hidden, from 0 when it is obvious and goes on stopping to 3 when it is silent and delayed, like tumour promotion or slow organ damage. User reports cannot reveal a harm that takes years to appear, so a high score here limits what good reviews can tell you.

Product

The risk of what people actually buy, from 0 for a regulated pharmacy or supplement product taken by mouth or on the skin to 3 for a grey-market injectable. In one dataset of 6,441 grey-market samples, 42–71% failed basic quality criteria and 15% carried endotoxin; taken by mouth or in the nose, a pack avoids the injection risks.

Evidence

The strongest kind of study behind the peptide's effects, from an approved drug through human controlled trials and small human studies to animal work or nothing of its own. Animal results often fail to carry over to people.

Access

How people get it: as an approved drug, a compounded prescription, an over-the-counter supplement or from the grey market, where nobody checks the vial. The channel decides both the legal position and the risk of a bad batch.

Price per month

Thirty days of the typical dose, from its low end to its high end, priced at the listing a careful buyer would choose: in stock, from a shop scoring 4 of 5 on trust (third-party tested where no score is set), failing that 3, a pure pack before a blend, a European shop first, then the cheapest per mg. The range is the dose's, not the shops'. A per-dose amount counts once a day unless the dose says otherwise. Prices are in euros at ECB rates of 2026-10-29, before shipping; the shop table keeps each listing's price per mg, per gram for bulk supplements. Where no listing can be priced the researchers' own estimate stands in, and says so.

Dose users report

The middle half of the daily doses stated in at least five first-hand reports, vendor posts left out. Where its middle sits more than twice above or below the declared dose, the month is priced at it as well, since what people take is what they pay for.

Shop trust

Each shop's trust on a 1–5 scale, read from its testing and its reputation: 1 for serious red flags (fabricated COAs, scam reports, impersonation, a closed shop), 2 for no public testing, a new shop or active complaints such as seized parcels, 3 for its own COAs or a short track record, 4 for verified third-party testing or a strong reputation, and 5 for third-party batch reports that name the shop, with years of good independent reputation. A shop without a score counts third-party batch testing as 4, its own COAs as 3 and no public tests as 2.

Best value

Within a category or a goal, a peptide that no other beats on both counts: none is rated more positively for the same or a lower monthly price, and none costs less for the same or a higher rating. The chart joins these into the best-value line; the cheapest of them and the best-rated of them both make it, so the line spans the trade-off from cheap to best. Avoid entries never count, and a peptide needs both a % positive and a price to be compared.

Testing

Whether the shop publishes lab results: third-party tested means an independent lab checks each batch, own COA means the shop's own certificate of analysis, and no public tests means neither. A certificate shows purity, not safety.

Added peptide

Some packs sold under one peptide's name hold a second one, such as 5 mg GHK-Cu in a nasal kit, stated only in the description. Sprayed in the nose or injected it reaches the blood like an injection, so it carries the risk of that route and is tiered as the injectable form, whatever its tier on the skin. A pack whose page gives no contents list may hold more than its name.